Innventure Targets $100M Annual Revenue for Accelsius by 2026, Marks Shift to Self-Funded Growth

Earnings Call Insights: Innventure, Inc. (INV) Q4 2025

Management View

Roland Austrup, Chief Growth Officer, stated, “This is the earnings call we have been building toward…for the first time in Innventure’s history, every part of this platform is firing at the same time, and the results are undeniable.” He emphasized that Innventure has shifted “from potential to performance” with “third-party validation, commercial bookings at scale, operational expansion, execution milestones delivered across our family of operating companies simultaneously.”

Austrup detailed that in 2026 Q1, Innventure’s operating companies generated over $50 million in new bookings in a single quarter, describing this as a “commercial inflection point.” He highlighted that Accelsius is scaling rapidly, AeroFlexx has expanded into prestige beauty, and Refinity has moved from formation to pilot-scale validation within a year.

CEO Gregory Haskell outlined Accelsius’s market, noting, “You cannot run that infrastructure without solving the thermal problem, you cannot.” He reported over $50 million in contracted backlog for Accelsius in Q1 2026 and expects revenue to be “heavily back-end weighted in 2026.”

Haskell indicated that Accelsius is on a path to exit 2026 at cash flow breakeven with an annual revenue run rate of approximately $100 million. He highlighted a $65 million Series B investment in Accelsius led by Johnson Controls and Legrand, valuing the company at $665 million post money.

On AeroFlexx, Haskell reported a global partnership with Aveda and a near-term commercial pipeline of just under $30 million, with a third in final negotiations. He noted AeroFlexx is targeting cash flow positivity in 2028.

Refinity was described as having moved from formation to producing its first metric ton of circular product in less than a year, with yields above 60%-70%. Haskell said, “Refinity is hitting KPIs ahead of schedule…and is positioning itself to scale just as the industry reenters a growth phase.”

CFO David Yablunosky stated, “The financial profile of this company is changing, not gradually, structurally and the numbers I’m about to give you are evidence of that change.”

Outlook

Management expects Accelsius to reach cash flow breakeven by December 2026 with an annual revenue run rate of about $100 million.

AeroFlexx is expected to reach cash flow positivity by 2028, supported by anchor customers and a growing commercial pipeline.

Yablunosky said, “We expect Accelsius to exit December 2026, and with positive operating cash flow, implying an annual revenue run rate of approximately $100 million.”

Operating companies are increasingly raising capital independently, with Innventure’s parent-level capital needs projected to be materially less in 2026.

Financial Results

Accelsius revenue increased from $0.3 million in 2024 to $1.6 million in 2025, driven by proof-of-concept deployments.

Consolidated 2025 revenue was $2.1 million, up from $1.2 million in 2024.

Consolidated G&A expense declined from $29.7 million in Q4 2024 to $11.5 million in Q4 2025, a 61% reduction.

Adjusted EBITDA for 2025 was a loss of $78.8 million, excluding a $347 million noncash goodwill adjustment.

As of year-end 2025, cash, restricted cash and equivalents were $65.4 million, up from $11.1 million at the end of 2024. A $40 million registered direct offering was completed in January 2026, and the remaining $5.6 million balance on convertible ventures was repaid.

Q&A

Alfred Moore, ROTH Capital Partners, LLC, asked about the diversity and scale of Accelsius’s customer base and the transition from pilot to commercial orders. CEO Haskell explained that most deliveries have moved beyond pilots and “most of the purchase orders are either 8 or even 9 figures in terms of scale.”

Moore inquired about AeroFlexx’s momentum and capital raise plans. Haskell described Aveda as a “framework deal that we think can be quite significant” and noted that AeroFlexx is seeing commercial-sized proposals.

Moore asked about further G&A optimization. Yablunosky responded, “We’re always focused on G&A…I can assure you, it’s on our radar, and we’re always looking at ways to operate more efficiency.”

Nehal Chokshi, Northland Capital Markets, questioned the COGS-to-revenue ratio. Haskell and Yablunosky attributed this to inventory buildup ahead of delivery and amortization of intangible assets.

Chokshi asked about independent capital raises by operating companies and potential dilution. Haskell explained, “If these companies are in a position, you’re mature enough to be able to raise capital independently, let’s raise some capital…Yes, we’ll take some dilution there, but we saved the permanent dilution at the Innventure level.”

Aashi Shah, Sidoti & Company, LLC, asked about brownfield deployments for Accelsius and Aveda partnership volumes. Haskell indicated that brownfield adoption timing is uncertain but anticipated to begin blending with greenfield deployments later in the year. He did not provide specific volume figures for Aveda.

Chokshi also asked about board independence. Haskell responded, “Today, we have 5 independent directors and 4 executive directors. And what we’re targeting is to go to 7 independents and 2 executive directors.”

Sentiment Analysis

Analysts pressed for detail on revenue conversion, margin normalization, capital structure, and operating company independence, displaying a slightly skeptical tone, especially regarding cost structure and pipeline conversion.

Management’s tone during prepared remarks was highly confident and assertive, using phrases such as “the waiting is over. The results are here. They are accelerating.” During Q&A, management was more measured, especially when discussing inventory, pipeline conversion, and dilution, but maintained a tone of progress and transparency.

Compared to the previous quarter, management’s confidence and level of detail increased, while analysts’ questions grew more specific and probing, especially around scaling, margins, and governance.

Quarter-over-Quarter Comparison

The current quarter saw a decisive shift from discussion of pipeline growth to citing contracted bookings and backlog, particularly at Accelsius.

Management provided a specific cash flow breakeven target for Accelsius by the end of 2026 and a detailed annual revenue run rate, whereas the previous quarter focused more on pipeline and early-stage deployments.

G&A expense reductions were emphasized in the current quarter, with a 61% year-over-year reduction, compared to sequential quarterly improvements previously.

Analysts’ focus shifted from pipeline and technology validation in Q3 to detailed questions about revenue recognition, order scale, margin structure, and board independence in Q4.

Management’s tone shifted towards strong execution and operational proof, while analysts became more granular in their scrutiny.

Risks and Concerns

Management acknowledged global supply chain constraints impacting delivery and revenue recognition timing for Accelsius, stating, “These constraints can affect the timing of delivery and revenue recognition even when customer demand and purchase orders are firmly in hand.”

Inventory write-downs were noted as a result of market evolution towards higher-capacity products.

Analysts raised concerns about cost of goods sold, margin visibility, inventory obsolescence, and the impact of independent capital raises on dilution.

Management emphasized ongoing cost discipline and forecasted further G&A optimization as operating companies become self-funding.

Final Takeaway

Management underscored that Innventure is transitioning from a capital-consuming platform to one increasingly self-funded by its operating companies. With over $50 million in new bookings in the first quarter of 2026, a clear line of sight to $100 million annual revenue run rate for Accelsius by year-end 2026, and significant cost reductions, the company signaled a structural shift in its financial profile. Operating companies are raising capital independently, reducing parent-level funding needs, and management expressed strong confidence in achieving consolidated cash flow positivity in 2028, while highlighting that recent commercial and operational milestones mark a decisive inflection in the company’s growth trajectory.